Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Endocrine Technology

Endocrine Technology
2002 FOUNDED
PRIVATE STATUS
Early Stage VC LATEST DEAL TYPE (Cancelled)
$20M LATEST DEAL AMOUNT
Description

Owner and operator of a biotechnology company. The company focuses on filing New patent applications for the therapy of diabetes and its complications.

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 326 Livingston Street
  • New York, NY 11217
  • United States

+1 (718) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Endocrine Technology’s full profile, request a free trial.

Endocrine Technology Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC $20M Cancelled Startup
2. Grant 00.00 00.00 Completed Startup
1. Angel (individual) $2.2M $2.2M Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Endocrine Technology Executive Team (1)

Name Title Board
Seat
Contact
Info
Kumarpal Shah MD Founder, Owner & President, Business Development